Genenta Science
GNTA
4 hedge funds and large institutions have $3.67M invested in Genenta Science in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
60% more capital invested
Capital invested by funds: $2.29M → $3.67M (+$1.38M)
33% more funds holding
Funds holding: 3 → 4 (+1)
2.13% more ownership
Funds ownership: 2.51% → 4.64% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$2M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.9K |
| 3 |
Morgan Stanley
New York
|
+$2.59K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank Julius Baer & Co
Zurich,
Switzerland
| $3.47M | +$2M | +385,313 | +93% |
|
|
AU
2
Algebris (UK)
London,
United Kingdom
| $186K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $11.4K | +$11.9K | +2,301 | New |
|
|
4
Morgan Stanley
New York
| $4.95K | +$2.59K | +500 | +100% |
|
GNTA Hedge Fund Activity: Q4 2023 in Review
4 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q4 2023, worth a combined $3.67M — up 60% from $2.29M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GNTA positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Bank Julius Baer & Co, adding an estimated $2M.
- 4 institutional investors held Genenta Science (GNTA) as of Q4 2023, up from 3 in Q3 2023.
- Funds reported $3.67M of Genenta Science stock for Q4 2023, up 60% quarter-over-quarter.
- 1 fund opened new Genenta Science positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest Genenta Science buyer in Q4 2023 was Bank Julius Baer & Co, an estimated $2M added.
Based on aggregated 13F filings for Q4 2023.